Harmony Biosciences Holdings, Inc. (HRMY)
39.41
+0.20
(+0.51%)
USD |
NASDAQ |
Aug 31, 16:00
39.41
0.00 (0.00%)
After-Hours: 19:22
Harmony Biosciences Holdings Total Long Term Debt (Quarterly) : 158.74M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 158.74M |
| March 31, 2026 | 163.34M |
| December 31, 2025 | 168.18M |
| September 30, 2025 | 168.91M |
| June 30, 2025 | 172.53M |
| March 31, 2025 | 176.32M |
| December 31, 2024 | 180.09M |
| September 30, 2024 | 183.71M |
| June 30, 2024 | 187.28M |
| March 31, 2024 | 191.27M |
| December 31, 2023 | 194.65M |
| September 30, 2023 | 198.03M |
| June 30, 2023 | 191.94M |
| March 31, 2023 | 192.30M |
| December 31, 2022 | 192.62M |
| Date | Value |
|---|---|
| September 30, 2022 | 193.11M |
| June 30, 2022 | 191.81M |
| March 31, 2022 | 191.90M |
| December 31, 2021 | 194.22M |
| September 30, 2021 | 192.07M |
| June 30, 2021 | 195.61M |
| March 31, 2021 | 194.91M |
| December 31, 2020 | 194.25M |
| September 30, 2020 | 192.86M |
| June 30, 2020 | 626.53M |
| March 31, 2020 | 614.82M |
| December 31, 2019 | 509.22M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Liquidia Corp. | 182.90M |
| Repligen Corp. | 671.62M |
| Johnson & Johnson | 37.34B |
| ACADIA Pharmaceuticals, Inc. | 59.55M |
| ANI Pharmaceuticals, Inc. | 610.49M |